Harpoon Therapeutics Q3 EPS $(0.65) Up From $(6.23) YoY, Sales $1.417M Up From $1.063M YoY

Harpoon Therapeutics (NASDAQ:HARP) reported quarterly losses of $(0.65) per share. This is a 89.57 percent increase over losses of $(6.23) per share from the same period last year. The company reported $1.417 million in

Benzinga · 11/06/2019 21:32

Harpoon Therapeutics (NASDAQ:HARP) reported quarterly losses of $(0.65) per share. This is a 89.57 percent increase over losses of $(6.23) per share from the same period last year. The company reported $1.417 million in sales this quarter. This is a 33.30 percent increase over sales of $1.063 million the same period last year.